Click to copy, then share by pasting into your messages, comments, social media posts and websites.
Click to copy, then add into your webpages so users can view and engage with this video from your site.
Report Content
We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.
Thank you for submitting your report
We will investigate and take the appropriate action.
Denmark Ditches Johnson and Johnson Covid Shots from Vaccine Programme 3/04/2021
3/04/2021
Denmark became the first country to drop the Johnson & Johnson Covid-19 shot from its vaccination programme owing to blood clot concerns, weeks after also excluding the Oxford/AstraZeneca jab. The Danish health authority said on Monday it had concluded that the benefits of the J&J vaccine did not outweigh its risks.
Denmark ditches Johnson and Johnson Covid shots from vaccine programme
Denmark on Monday became the first country to exclude Johnson & Johnson's Covid-19 shots from its vaccination programme over a potential link to a rare but serious form of blood clot.
The move comes after the Nordic country last month stopped using AstraZeneca's vaccine altogether citing similar concerns.
The country's health authority said in a statement it had found that "the benefits of using the Covid-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect in those who receive the vaccine".
Excluding the J&J vaccine, which accounts for around a third of Denmark's total contracted supplies of Covid-19 shots, would delay the country's vaccination calendar by up to four weeks, it said.
Denmark, which has so far fully vaccinated 11.5 per cent of its population, has gradually been reopening society since early March as infection rates has slowed, including indoor service at restaurants and cafes and allowing football fans into stadiums.
Taking the present situation in Denmark into account, what we are currently losing in our effort to prevent severe illness from Covid-19 cannot outweigh the risk of causing possible side effects in the form of severe blood clots in those we vaccinate," the health authority said.
It added that the vaccination rollout is progressing satisfactorily with other available vaccines.
Lawmakers at a meeting on Monday agreed to allow voluntary use of the shots from both Johnson & Johnson and AstraZeneca, lawmaker Liselott Blixt of the Danish People's Party told Reuters.
The rollout of J&J's vaccine has also been delayed elsewhere in Europe over similar clotting concerns.
Europe's drug regulator, the European Medicines Agency (EMA), said on April 20th it had found a possible link between J&J's vaccine and rare blood clotting issues in adults who received doses in the United States.
However, it backed the vaccine's overall benefits against any risks. Since then, several European countries have resumed administering the vaccine.
The EMA said its safety committee had concluded that a warning about unusual blood clots with low platelets must be added to the vaccine's labels, just as was required of AstraZeneca. J&J said in a news release that it would comply with that measure.
Category | None |
Sensitivity | Normal - Content that is suitable for ages 16 and over |
Playing Next
Related Videos
The NUMBER OF MAGNETIZED AFTER THE VACCINE 14/07/2021
2 years, 9 months ago
British couple with Indian jab taken off flight to Malta 13/07/2021
2 years, 9 months ago
Facebook Wants To Know If You've Been Exposed to Extremism 13/07/2021
2 years, 9 months ago
THIS WEEK with Mary & Polly - Latest News - July 13th 2021
2 years, 9 months ago
CATHERINE AUSTIN FITTS ON CENTRAL BANK DIGITAL CONTROL! 10/07/2021
2 years, 9 months ago
Warning - This video exceeds your sensitivity preference!
To dismiss this warning and continue to watch the video please click on the button below.
Note - Autoplay has been disabled for this video.